Scotia Capital Inc. increased its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,853 shares of the company’s stock after acquiring an additional 3,478 shares during the […]
Scotia Capital Inc. increased its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 46,853 shares of the company’s stock after acquiring an additional 3,478 shares during the quarter. […]
Bank of Nova Scotia increased its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 83.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 500,427 shares of the company’s stock after acquiring an additional 228,341 shares during the period. Bank of Nova Scotia […]
Chesapeake Wealth Management lowered its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 5.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,181 shares of the company’s stock after selling 236 shares during the quarter. Chesapeake Wealth Management’s holdings […]
Adams Wealth Management bought a new position in Eli Lilly and Company (NYSE:LLY – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 349 shares of the company’s stock, valued at approximately $204,000. A number of other institutional investors and hedge funds […]